Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

PMCBD

PharmaCyte Biotech (OTCMKTS:PMCBD) Continues to be Under Selling Pressure: Now What?

Biotech company PharmaCyte Biotech (OTCMKTS:PMCBD), focused on developing cellular therapies for cancer and diabetes, on July 13 announced that post storage for 3 years, the original cytochrome P450 expressing cells from PharmaCyte’s Master Cell Bank (MCB) manufactured by Eurofins Lancaster Laboratories still have excellent enzymatic activity and viable, elements critical for stability. The study is …

Continue reading “PharmaCyte Biotech (OTCMKTS:PMCBD) Continues to be Under Selling Pressure: Now What?”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.